Deregulation of long intergenic non-coding RNAs in CD4+ T cells of lamina propria in Crohn's disease through transcriptome profiling.
The etiology of Crohn's disease (CD) involves immune dysregulation in a genetically susceptible individual. GWAS studies have identified 200 loci associated with CD, ulcerative colitis or both, most of which fall within non-coding DNA regions. Long non-coding RNAs (lncRNAs) regulate gene expression by diverse mechanisms and have been associated with disease activity in inflammatory bowel disease. However, disease-associated lncRNAs have not been characterized in pathogenic immune cell populations. Terminal ileal samples were obtained from 22 CD patients and 13 controls. RNA from lamina propria CD4+ T cells was sequenced and long intergenic non-coding RNAs (lincRNAs) detected. Overall expression patterns, differential expression (DE), pathway and gene enrichment analyses performed. Knockdown of novel lincRNAs XLOC_000261 and XLOC_000014 was performed. Expression of Th1 or Th17-associated transcription factors, T-bet and RORγt, respectively, was assessed by flow cytometry. A total of 6,402 lincRNAs were expressed, 960 of which were novel. Unsupervised clustering and principal component analysis showed the lincRNA expression discriminated patients from controls. A total of 1792 lincRNAs were DE and 295 (79 novel; 216 known) mapped to 267 of 5,727 DE protein-coding genes. The novel lincRNAs enriched in inflammatory and Notch signaling pathways (p<0.05). Furthermore, DE lincRNAs in CD patients were more frequently found in DNA regions with known IBD associated loci. The novel lincRNA XLOC_000261 negatively regulated RORγt expression in Th17 cells. We describe a novel set of DE lincRNAs in CD-associated-CD4+ cells and demonstrate that novel lincRNA XLOC_000261 appears to negatively regulate RORγt protein expression in Th17 cells.